Jizhou Wang

机构：University of Science and Technology of China, Anhui Provincial Center for Disease Control and Prevention, Anhui Provincial Hospital, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-6934-072X

发表论文 77 篇 · 总被引 1905 次 · h-index 20

代表论文

• RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma (2025 · Nature Cancer · 被引 24)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment (2024 · HepatoBiliary Surgery and Nutrition · 被引 10)
• Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospective multi-center cohort study (2024 · Journal of Gastroenterology · 被引 7)
• Susceptibility Modeling and Potential Risk Analysis of Thermokarst Hazard in Qinghai–Tibet Plateau Permafrost Landscapes Using a New Interpretable Ensemble Learning Method (2024 · Atmosphere · 被引 5)
• Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation (2025 · Journal of Hepatocellular Carcinoma · 被引 4)